| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | 9.72e-05 | 749 | 30 | 7 | GO:0005509 | |
| GeneOntologyBiologicalProcess | positive regulation of platelet activation | 1.00e-06 | 14 | 30 | 3 | GO:0010572 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 2.36e-05 | 410 | 30 | 6 | GO:0031589 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 1.01e-04 | 169 | 30 | 4 | GO:0010977 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 1.19e-04 | 66 | 30 | 3 | GO:0010543 | |
| GeneOntologyBiologicalProcess | transition between fast and slow fiber | 1.58e-04 | 13 | 30 | 2 | GO:0014883 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.84e-04 | 14 | 30 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | positive regulation of response to wounding | 3.30e-04 | 93 | 30 | 3 | GO:1903036 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 3.45e-04 | 233 | 30 | 4 | GO:0031345 | |
| GeneOntologyBiologicalProcess | regulation of integrin activation | 3.82e-04 | 20 | 30 | 2 | GO:0033623 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle adaptation | 3.82e-04 | 20 | 30 | 2 | GO:0014733 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 4.78e-04 | 254 | 30 | 4 | GO:0010810 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 5.08e-04 | 23 | 30 | 2 | GO:2001044 | |
| GeneOntologyBiologicalProcess | cell migration in hindbrain | 5.08e-04 | 23 | 30 | 2 | GO:0021535 | |
| GeneOntologyBiologicalProcess | blood coagulation | 5.22e-04 | 260 | 30 | 4 | GO:0007596 | |
| GeneOntologyBiologicalProcess | coagulation | 5.69e-04 | 266 | 30 | 4 | GO:0050817 | |
| GeneOntologyBiologicalProcess | hemostasis | 5.85e-04 | 268 | 30 | 4 | GO:0007599 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 6.02e-04 | 270 | 30 | 4 | GO:0007160 | |
| GeneOntologyBiologicalProcess | wound healing | 6.65e-04 | 493 | 30 | 5 | GO:0042060 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | 7.33e-04 | 1077 | 30 | 7 | GO:0098609 | |
| GeneOntologyBiologicalProcess | integrin activation | 8.10e-04 | 29 | 30 | 2 | GO:0033622 | |
| GeneOntologyCellularComponent | perikaryon | 1.51e-05 | 223 | 30 | 5 | GO:0043204 | |
| GeneOntologyCellularComponent | dendrite | 1.70e-04 | 858 | 30 | 7 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 1.73e-04 | 860 | 30 | 7 | GO:0097447 | |
| GeneOntologyCellularComponent | neuronal cell body | 1.04e-03 | 835 | 30 | 6 | GO:0043025 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 1.46e-03 | 1228 | 30 | 7 | GO:0036477 | |
| GeneOntologyCellularComponent | cell body | 1.80e-03 | 929 | 30 | 6 | GO:0044297 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.23e-03 | 656 | 30 | 5 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.26e-03 | 658 | 30 | 5 | GO:0030312 | |
| Domain | EGF | 7.26e-08 | 235 | 30 | 7 | SM00181 | |
| Domain | EGF-like_dom | 1.08e-07 | 249 | 30 | 7 | IPR000742 | |
| Domain | EGF_CA | 1.37e-06 | 122 | 30 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.48e-06 | 124 | 30 | 5 | IPR001881 | |
| Domain | EGF_3 | 1.72e-06 | 235 | 30 | 6 | PS50026 | |
| Domain | EGF_1 | 2.75e-06 | 255 | 30 | 6 | PS00022 | |
| Domain | EGF-like_CS | 3.15e-06 | 261 | 30 | 6 | IPR013032 | |
| Domain | EGF_2 | 3.44e-06 | 265 | 30 | 6 | PS01186 | |
| Domain | EGF_CA | 1.05e-05 | 86 | 30 | 4 | PF07645 | |
| Domain | - | 1.49e-05 | 4 | 30 | 2 | 3.90.1460.10 | |
| Domain | GTF2I | 1.49e-05 | 4 | 30 | 2 | IPR004212 | |
| Domain | GTF2I | 1.49e-05 | 4 | 30 | 2 | PS51139 | |
| Domain | GTF2I | 1.49e-05 | 4 | 30 | 2 | PF02946 | |
| Domain | EGF | 4.72e-05 | 126 | 30 | 4 | PF00008 | |
| Domain | Sushi | 7.84e-05 | 52 | 30 | 3 | PF00084 | |
| Domain | CCP | 8.78e-05 | 54 | 30 | 3 | SM00032 | |
| Domain | SUSHI | 9.79e-05 | 56 | 30 | 3 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.03e-04 | 57 | 30 | 3 | IPR000436 | |
| Domain | - | 1.36e-04 | 11 | 30 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 1.36e-04 | 11 | 30 | 2 | IPR023413 | |
| Domain | TSP_1 | 1.39e-04 | 63 | 30 | 3 | PF00090 | |
| Domain | TSP1 | 1.53e-04 | 65 | 30 | 3 | SM00209 | |
| Domain | TSP1_rpt | 1.53e-04 | 65 | 30 | 3 | IPR000884 | |
| Domain | TSP1 | 1.53e-04 | 65 | 30 | 3 | PS50092 | |
| Domain | PLAC | 2.24e-04 | 14 | 30 | 2 | PF08686 | |
| Domain | - | 2.24e-04 | 74 | 30 | 3 | 3.40.50.410 | |
| Domain | VWFA | 3.04e-04 | 82 | 30 | 3 | PS50234 | |
| Domain | VWA | 3.26e-04 | 84 | 30 | 3 | SM00327 | |
| Domain | PLAC | 4.19e-04 | 19 | 30 | 2 | IPR010909 | |
| Domain | PLAC | 4.19e-04 | 19 | 30 | 2 | PS50900 | |
| Domain | - | 4.69e-04 | 95 | 30 | 3 | 2.60.120.200 | |
| Domain | EGF_Ca-bd_CS | 4.98e-04 | 97 | 30 | 3 | IPR018097 | |
| Domain | EGF_CA | 5.29e-04 | 99 | 30 | 3 | PS01187 | |
| Domain | VWF_A | 5.29e-04 | 99 | 30 | 3 | IPR002035 | |
| Domain | ASX_HYDROXYL | 5.44e-04 | 100 | 30 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.45e-04 | 106 | 30 | 3 | IPR000152 | |
| Domain | Ephrin_rec_like | 7.31e-04 | 25 | 30 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 7.31e-04 | 25 | 30 | 2 | IPR011641 | |
| Domain | Znf_C2H2-like | 1.45e-03 | 796 | 30 | 6 | IPR015880 | |
| Domain | ZnF_C2H2 | 1.57e-03 | 808 | 30 | 6 | SM00355 | |
| Domain | Growth_fac_rcpt_ | 1.97e-03 | 156 | 30 | 3 | IPR009030 | |
| Domain | Ig_I-set | 3.44e-03 | 190 | 30 | 3 | IPR013098 | |
| Domain | I-set | 3.44e-03 | 190 | 30 | 3 | PF07679 | |
| Domain | VWA | 3.64e-03 | 56 | 30 | 2 | PF00092 | |
| Domain | Laminin_G | 3.90e-03 | 58 | 30 | 2 | IPR001791 | |
| Domain | ConA-like_dom | 5.11e-03 | 219 | 30 | 3 | IPR013320 | |
| Domain | RNaseH-like_dom | 5.47e-03 | 69 | 30 | 2 | IPR012337 | |
| Domain | IGc2 | 6.21e-03 | 235 | 30 | 3 | SM00408 | |
| Domain | Ig_sub2 | 6.21e-03 | 235 | 30 | 3 | IPR003598 | |
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 7.19e-07 | 2 | 30 | 2 | 15388857 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 15100712 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 27943541 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 21328569 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 17823943 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 23229069 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 22899722 | ||
| Pubmed | 3.22e-05 | 10 | 30 | 2 | 26627825 | ||
| Pubmed | 3.75e-05 | 75 | 30 | 3 | 20637190 | ||
| Pubmed | 5.58e-05 | 13 | 30 | 2 | 14557872 | ||
| Pubmed | Transcriptional fates of human-specific segmental duplications in brain. | 1.22e-04 | 19 | 30 | 2 | 30228200 | |
| Pubmed | 2.49e-04 | 27 | 30 | 2 | 24586749 | ||
| Pubmed | Analysis of the Tropism of SARS-CoV-2 Based on the Host Interactome of the Spike Protein. | 3.29e-04 | 31 | 30 | 2 | 37939376 | |
| Pubmed | Genome-wide association study of lung function decline in adults with and without asthma. | 3.51e-04 | 32 | 30 | 2 | 22424883 | |
| Pubmed | 4.70e-04 | 37 | 30 | 2 | 20236931 | ||
| Pubmed | 4.70e-04 | 37 | 30 | 2 | 38011284 | ||
| Pubmed | Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach. | 4.96e-04 | 38 | 30 | 2 | 16263699 | |
| Pubmed | Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. | 5.23e-04 | 39 | 30 | 2 | 19010793 | |
| Pubmed | 6.35e-04 | 43 | 30 | 2 | 21116278 | ||
| Pubmed | 8.25e-04 | 49 | 30 | 2 | 21362503 | ||
| Cytoband | 7q11.23 | 1.85e-03 | 97 | 30 | 2 | 7q11.23 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.34e-05 | 57 | 18 | 3 | 1179 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.13e-04 | 161 | 18 | 3 | 593 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.84e-03 | 718 | 18 | 4 | 28 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP | 3.15e-06 | 202 | 30 | 5 | M38982 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 4.78e-05 | 355 | 30 | 5 | M45758 | |
| Coexpression | DESCARTES_FETAL_LUNG_MEGAKARYOCYTES | 5.13e-05 | 180 | 30 | 4 | M40239 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 6.46e-05 | 191 | 30 | 4 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 7.14e-05 | 196 | 30 | 4 | M3008 | |
| Coexpression | NABA_MATRISOME | 1.14e-04 | 1008 | 30 | 7 | MM17056 | |
| Coexpression | NABA_MATRISOME | 1.27e-04 | 1026 | 30 | 7 | M5889 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT | 1.49e-04 | 90 | 30 | 3 | M38984 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_VASCULAR_SMOOTH_MUSCLE_CELLS | 1.64e-04 | 93 | 30 | 3 | M39279 | |
| Coexpression | NABA_CORE_MATRISOME | 2.44e-04 | 270 | 30 | 4 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 2.62e-04 | 275 | 30 | 4 | M5884 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.08e-06 | 310 | 30 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 8.87e-06 | 777 | 30 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.23e-05 | 32 | 30 | 3 | gudmap_kidney_adult_RenalCapsule_k1_1000 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_100 | 8.62e-05 | 10 | 30 | 2 | gudmap_kidney_P1_CapMes_Crym_k2_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 9.47e-05 | 793 | 30 | 7 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.91e-05 | 336 | 30 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 1.25e-04 | 69 | 30 | 3 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.63e-04 | 197 | 30 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.97e-04 | 207 | 30 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#2_top-relative-expression-ranked_200 | 2.09e-04 | 82 | 30 | 3 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_200_k2 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_100 | 3.25e-04 | 19 | 30 | 2 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_100 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 4.38e-04 | 22 | 30 | 2 | gudmap_kidney_P0_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.42e-04 | 256 | 30 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.03e-04 | 265 | 30 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.46e-07 | 185 | 30 | 5 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.67e-07 | 190 | 30 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.90e-07 | 195 | 30 | 5 | 4dba732c8d8ecf0ed9ece1814dc4060402199ed9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.04e-07 | 198 | 30 | 5 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-07 | 200 | 30 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-07 | 200 | 30 | 5 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-07 | 200 | 30 | 5 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-07 | 200 | 30 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-07 | 200 | 30 | 5 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-06 | 168 | 30 | 4 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.11e-06 | 171 | 30 | 4 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.47e-06 | 174 | 30 | 4 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-06 | 176 | 30 | 4 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-06 | 176 | 30 | 4 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 6.40e-06 | 181 | 30 | 4 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 7.28e-06 | 187 | 30 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 7.28e-06 | 187 | 30 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.43e-06 | 188 | 30 | 4 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.59e-06 | 189 | 30 | 4 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-06 | 190 | 30 | 4 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-06 | 190 | 30 | 4 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | facs-MAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-06 | 191 | 30 | 4 | b4fba92f9bd1354a07fedfca7304a3757e6d5beb | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-06 | 191 | 30 | 4 | e518c598719119e60c76016c586b1520c258bbcb | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-06 | 191 | 30 | 4 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.91e-06 | 191 | 30 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-06 | 191 | 30 | 4 | f0c649bb32732c9dd38a0af8ce94d2a4d16de39a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.08e-06 | 192 | 30 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.24e-06 | 193 | 30 | 4 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.41e-06 | 194 | 30 | 4 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 8.41e-06 | 194 | 30 | 4 | 2260cd817a6661e5eb6645b0c6786e18fd58371e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.58e-06 | 195 | 30 | 4 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.76e-06 | 196 | 30 | 4 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.76e-06 | 196 | 30 | 4 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-06 | 196 | 30 | 4 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.76e-06 | 196 | 30 | 4 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | P07-Mesenchymal-myocytic_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.94e-06 | 197 | 30 | 4 | 378299fe2ec6ed2fc858febb78ff1ac0898e457d | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.12e-06 | 198 | 30 | 4 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.12e-06 | 198 | 30 | 4 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.12e-06 | 198 | 30 | 4 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 9.12e-06 | 198 | 30 | 4 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.12e-06 | 198 | 30 | 4 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.30e-06 | 199 | 30 | 4 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 9.30e-06 | 199 | 30 | 4 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.30e-06 | 199 | 30 | 4 | 3368c0a90a47c4dcdfe70be3192550df0744e508 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.30e-06 | 199 | 30 | 4 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.30e-06 | 199 | 30 | 4 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.49e-06 | 200 | 30 | 4 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.49e-06 | 200 | 30 | 4 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 9.49e-06 | 200 | 30 | 4 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.49e-06 | 200 | 30 | 4 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.49e-06 | 200 | 30 | 4 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 9.49e-06 | 200 | 30 | 4 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 9.49e-06 | 200 | 30 | 4 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.49e-06 | 200 | 30 | 4 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-3|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.39e-05 | 102 | 30 | 3 | 57a30ef6ac6ee623bb328b945a9d7c9a56d40a4e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.63e-05 | 128 | 30 | 3 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 8.83e-05 | 129 | 30 | 3 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | COVID-19-kidney-Technical/muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.10e-04 | 139 | 30 | 3 | 13247bcb21c57c808657e0f543d6f134eeea7cc1 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 1.10e-04 | 139 | 30 | 3 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 1.33e-04 | 148 | 30 | 3 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.35e-04 | 149 | 30 | 3 | 5293c50b3fb41b1edaf9a97354899bd13770078c | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Platelets-Platelets|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-04 | 152 | 30 | 3 | aff7d1127ef72be489477611c4decc53cc7632e3 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Platelets|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-04 | 152 | 30 | 3 | 0a99c91165e4d82fb8825fbdf3071c9a5445669d | |
| ToppCell | VE-Treg-naive_CD4|VE / Condition, Cell_class and T cell subcluster | 1.55e-04 | 156 | 30 | 3 | 6501baf73616e702946de9fb13d267e30a68888b | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.58e-04 | 157 | 30 | 3 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.64e-04 | 159 | 30 | 3 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 160 | 30 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.67e-04 | 160 | 30 | 3 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 160 | 30 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 1.70e-04 | 161 | 30 | 3 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 1.83e-04 | 165 | 30 | 3 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 166 | 30 | 3 | 13027ae342994db4540e64eb910df1f42b160931 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 166 | 30 | 3 | b21e45bd43f26149b9cd6e45c19241c82d54fb2f | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-endocardial_endothelial_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 167 | 30 | 3 | a4a795751644b22af616335379e64ae95175180c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-04 | 167 | 30 | 3 | 4e613be2b3ba01160b0c0254fce3c4f72220e580 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.89e-04 | 167 | 30 | 3 | d2230c894ccf9dbba9196e079ae81f384d43da63 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-04 | 167 | 30 | 3 | c7d1e84af1f4d7430858287520ac2cfa36203642 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 167 | 30 | 3 | 40d102e01ccbc7262d00fafd59ca5234909009cb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-04 | 167 | 30 | 3 | 18ad85751bd892309627eefc357eb28ec5a7c300 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.93e-04 | 168 | 30 | 3 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.96e-04 | 169 | 30 | 3 | bddb28a8b9afbe4a68f082e82caf96a6666fc674 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.96e-04 | 169 | 30 | 3 | 5ce46bac8e767feec7ecdc61689de225c49bd3f7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.96e-04 | 169 | 30 | 3 | 2abdd8ae9a5d88aac30992142d1b502c959bc015 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.00e-04 | 170 | 30 | 3 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.03e-04 | 171 | 30 | 3 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-04 | 172 | 30 | 3 | e39ea2f4edbf36ebf9604fa6f9349081859c596c | |
| ToppCell | PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-04 | 172 | 30 | 3 | bcc50bed47465daa953ba91f17d1ee4c947ab461 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-04 | 172 | 30 | 3 | 875ea290840e835952623b905eb610f3c71456d2 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-04 | 174 | 30 | 3 | 40bb87d219aafab0357ab0d797efd38085fc0312 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-04 | 175 | 30 | 3 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-04 | 175 | 30 | 3 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-04 | 175 | 30 | 3 | bc6bd8c3ce956245ef4db91af9501649d5c09478 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 30 | 3 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 30 | 3 | eb63eb2c301e785196ccadac74a2940b2c524c62 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 30 | 3 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.25e-04 | 177 | 30 | 3 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.29e-04 | 178 | 30 | 3 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 178 | 30 | 3 | 5cc182e6faa7ba5b88378d2c953be29bbbb95a7e | |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.29e-04 | 178 | 30 | 3 | ccd37575b60102f5e647c01546e8ff8fec638bd7 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 178 | 30 | 3 | f9a16bc3f09c35c7d30e3809da024bc2dcf746ed | |
| Disease | vascular brain injury measurement, vascular brain injury | 7.74e-05 | 13 | 30 | 2 | EFO_0006791, EFO_0006800 | |
| Disease | vital capacity | 1.94e-04 | 1236 | 30 | 7 | EFO_0004312 | |
| Disease | Nephritis, Interstitial | 2.72e-04 | 24 | 30 | 2 | C0027707 | |
| Disease | attempted suicide | 7.77e-04 | 178 | 30 | 3 | EFO_0004321 | |
| Disease | open-angle glaucoma | 9.53e-04 | 191 | 30 | 3 | EFO_0004190 | |
| Disease | disease progression measurement, Crohn's disease | 1.05e-03 | 47 | 30 | 2 | EFO_0000384, EFO_0008336 | |
| Disease | body fat distribution | 1.12e-03 | 202 | 30 | 3 | EFO_0004341 | |
| Disease | idiopathic osteonecrosis of the femoral head | 1.28e-03 | 52 | 30 | 2 | EFO_1001930 | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 1.36e-03 | 216 | 30 | 3 | EFO_0007925, EFO_0007927 | |
| Disease | skin neoplasm | 2.58e-03 | 74 | 30 | 2 | EFO_0004198 | |
| Disease | nicotine dependence symptom count | 2.98e-03 | 285 | 30 | 3 | EFO_0009262 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PMCKVVNCSDPGIPA | 2926 | Q7Z407 | |
| ADLCKKCQMQPGHPL | 1241 | Q92824 | |
| CRKHKMPPPQAFTCN | 546 | Q8IXI2 | |
| MMCIVKPDGPPQLCK | 731 | Q9P265 | |
| CQPECKNKVVGPELP | 551 | Q14678 | |
| CSVCKEPIMPAPGQE | 536 | Q93052 | |
| MACVCPKGVPPQKDQ | 551 | Q3SXY7 | |
| KMCQEAAVPKILPCP | 231 | Q9BXL5 | |
| RPCMDINECEQVPKP | 5311 | Q96RW7 | |
| IDGPSKVKMDCQECP | 2466 | P21333 | |
| NDPCVEKPCPGDMQC | 3796 | Q8TDW7 | |
| LMKPNAVPKACCAPT | 356 | Q7Z5Y6 | |
| PQKLQMPPCSECEVK | 311 | Q86TE4 | |
| MPPCSECEVKKAPEK | 316 | Q86TE4 | |
| QCPPLKIPERGNMTC | 261 | P16109 | |
| CEVKPPCPVNGMQVH | 86 | Q86UP8 | |
| CEVKPPCPVNGMQVH | 86 | Q6EKJ0 | |
| NAPPAKLACPVCSKM | 36 | Q9Y2M0 | |
| DMNGKPTNCKPPDCH | 486 | Q96PQ0 | |
| DQLQQKIMCPGPVTC | 71 | Q9BV38 | |
| KNCAEPIKCKAPGNP | 1781 | Q4LDE5 | |
| LCNSPSPQMNGKPCE | 461 | P07996 | |
| CQSPPMKTQTVEKPC | 176 | Q15935 | |
| GTPKPSGVQMDQPCC | 281 | Q99962 | |
| CGQQPEKKDLQPMEP | 686 | Q6IQ55 | |
| QPVNLCKPSPCMNEG | 711 | Q5GFL6 | |
| KAMPCQVCKKVLEPN | 341 | O15060 | |
| VSPKKAHPCEMCGPI | 86 | E7ETH6 | |
| DCIPPNKVTMAGQCK | 136 | Q9BXT5 | |
| VSPKKAHPCEMCGPI | 86 | B7Z6K7 | |
| PKPKVMQTCNLFDCP | 466 | P82987 |